| 1 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 6.8 | JCR Q1 |
| 2 | Journal of Neuroimmune Pharmacology | 6.1 | JCR Q1 |
| 3 | Antibiotics-Basel | 5.5 | JCR Q1 |
| 4 | JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 5.5 | JCR Q1 |
| 5 | JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 5.2 | JCR Q1 |
| 6 | TOXICOLOGY | 5.2 | JCR Q1 |
| 7 | AAPS PHARMSCITECH | 5.1 | JCR Q1 |
| 8 | ADMET and DMPK | 5.1 | JCR Q1 |
| 9 | EXPERT OPINION ON THERAPEUTIC TARGETS | 5.1 | JCR Q1 |
| 10 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 5 | JCR Q1 |
| 11 | Biomolecules & Therapeutics | 4.9 | JCR Q1 |
| 12 | Advanced Pharmaceutical Bulletin | 4.7 | JCR Q1 |
| 13 | DRUG METABOLISM REVIEWS | 4.7 | JCR Q1 |
| 14 | EXPERT OPINION ON THERAPEUTIC PATENTS | 4.7 | JCR Q1 |
| 15 | JOURNAL OF DRUG TARGETING | 4.7 | JCR Q1 |
| 16 | JOURNAL OF LIPOSOME RESEARCH | 4.7 | JCR Q1 |
| 17 | Journal of Pharmaceutical Investigation | 4.7 | JCR Q1 |
| 18 | Pharmaceutical Medicine | 4.7 | JCR Q1 |
| 19 | Environmental Toxicology and Pharmacology | 4.6 | JCR Q1 |
| 20 | Expert Review of Anti-Infective Therapy | 4.6 | JCR Q1 |
| 21 | Biomedicines | 4.5 | JCR Q2 |
| 22 | Expert Opinion on Drug Metabolism & Toxicology | 4.5 | JCR Q1 |
| 23 | Pharmacological Reports | 4.5 | JCR Q2 |
| 24 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 4.3 | JCR Q2 |
| 25 | Expert Review of Neurotherapeutics | 4.3 | JCR Q1 |
| 26 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4.3 | JCR Q2 |
| 27 | REGULATORY TOXICOLOGY AND PHARMACOLOGY | 4.3 | JCR Q1 |
| 28 | SAUDI PHARMACEUTICAL JOURNAL | 4.3 | JCR Q2 |
| 29 | DRUG DEVELOPMENT RESEARCH | 4.2 | JCR Q2 |
| 30 | PHARMACEUTICAL RESEARCH | 4.1 | JCR Q2 |
| 31 | SKIN PHARMACOLOGY AND PHYSIOLOGY | 4.1 | JCR Q1 |
| 32 | ACS Pharmacology & Translational Science | 4 | JCR Q2 |
| 33 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 4 | JCR Q2 |
| 34 | PHARMACOTHERAPY | 4 | JCR Q2 |
| 35 | JAC-Antimicrobial Resistance | 3.9 | JCR Q2 |
| 36 | JOURNAL OF PHARMACEUTICAL SCIENCES | 3.9 | JCR Q2 |
| 37 | EXPERT OPINION ON EMERGING DRUGS | 3.8 | JCR Q2 |
| 38 | NEUROTOXICOLOGY | 3.8 | JCR Q2 |
| 39 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 3.8 | JCR Q2 |
| 40 | CLINICAL THERAPEUTICS | 3.7 | JCR Q2 |
| 41 | Journal of Global Antimicrobial Resistance | 3.7 | JCR Q2 |
| 42 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 3.7 | JCR Q2 |
| 43 | Journal of Psychedelic Studies | 3.7 | JCR Q1 |
| 44 | VASCULAR PHARMACOLOGY | 3.7 | JCR Q2 |
| 45 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 3.6 | JCR Q2 |
| 46 | DRUG METABOLISM AND DISPOSITION | 3.6 | JCR Q2 |
| 47 | Expert Review of Clinical Pharmacology | 3.6 | JCR Q2 |
| 48 | TOXICOLOGY AND APPLIED PHARMACOLOGY | 3.6 | JCR Q2 |
| 49 | ARCHIV DER PHARMAZIE | 3.5 | JCR Q2 |
| 50 | BMC Pharmacology & Toxicology | 3.5 | JCR Q2 |
| 51 | CARDIOVASCULAR DRUGS AND THERAPY | 3.5 | JCR Q2 |
| 52 | ChemMedChem | 3.5 | JCR Q2 |
| 53 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 3.5 | JCR Q2 |
| 54 | PEPTIDES | 3.5 | JCR Q2 |
| 55 | AAPS Journal | 3.4 | JCR Q2 |
| 56 | Clinical Psychopharmacology and Neuroscience | 3.4 | JCR Q2 |
| 57 | EXPERT OPINION ON PHARMACOTHERAPY | 3.4 | JCR Q2 |
| 58 | INVESTIGATIONAL NEW DRUGS | 3.4 | JCR Q2 |
| 59 | Journal of Pharmaceutical and Biomedical Analysis | 3.4 | JCR Q2 |
| 60 | ANTIVIRAL THERAPY | 3.3 | JCR Q2 |
| 61 | CNS & Neurological Disorders-Drug Targets | 3.3 | JCR Q2 |
| 62 | JOURNAL OF FOOD AND DRUG ANALYSIS | 3.3 | JCR Q2 |
| 63 | Journal of Managed Care & Specialty Pharmacy | 3.3 | JCR Q2 |
| 64 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 3.3 | JCR Q2 |
| 65 | PSYCHOPHARMACOLOGY | 3.3 | JCR Q2 |
| 66 | CURRENT MEDICINAL CHEMISTRY | 3.2 | JCR Q2 |
| 67 | Infection and Drug Resistance | 3.2 | JCR Q2 |
| 68 | International Journal of Clinical Pharmacy | 3.2 | JCR Q2 |
| 69 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION | 3.1 | JCR Q1 |
| 70 | CLINICAL DRUG INVESTIGATION | 3.1 | JCR Q2 |
| 71 | IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | 3.1 | JCR Q2 |
| 72 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3 | JCR Q2 |
| 73 | Expert Opinion On Drug Safety | 3 | JCR Q2 |
| 74 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 3 | JCR Q2 |
| 75 | ALCOHOL | 2.9 | JCR Q2 |
| 76 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 2.9 | JCR Q2 |
| 77 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2.9 | JCR Q2 |
| 78 | PharmaNutrition | 2.9 | JCR Q2 |
| 79 | Cardiovascular Therapeutics | 2.8 | JCR Q2 |
| 80 | CPT-Pharmacometrics & Systems Pharmacology | 2.8 | JCR Q3 |
| 81 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | 2.8 | JCR Q2 |
| 82 | Journal of Pharmacological Sciences | 2.8 | JCR Q3 |
| 83 | PHARMACOGENOMICS JOURNAL | 2.8 | JCR Q2 |
| 84 | TOXICON | 2.8 | JCR Q3 |
| 85 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2.7 | JCR Q3 |
| 86 | Therapeutic Advances in Chronic Disease | 2.7 | JCR Q3 |
| 87 | Drug Testing and Analysis | 2.6 | JCR Q3 |
| 88 | Exploratory Research in Clinical and Social Pharmacy | 2.6 | JCR Q3 |
| 89 | Journal of Pharmaceutical Policy and Practice | 2.6 | JCR Q2 |
| 90 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2.6 | JCR Q2 |
| 91 | Pharmacology Research & Perspectives | 2.6 | JCR Q3 |
| 92 | World Journal of Traditional Chinese Medicine | 2.6 | JCR Q2 |
| 93 | ANNALS OF PHARMACOTHERAPY | 2.5 | JCR Q3 |
| 94 | Cannabis and Cannabinoid Research | 2.5 | JCR Q3 |
| 95 | DRUGS IN R&D | 2.5 | JCR Q3 |
| 96 | CHIRALITY | 2.4 | JCR Q2 |
| 97 | Integrated Pharmacy Research and Practice | 2.4 | JCR Q3 |
| 98 | Pharmacoeconomics-Open | 2.4 | JCR Q2 |
| 99 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 2.4 | JCR Q2 |
| 100 | Recent Patents on Anti-Cancer Drug Discovery | 2.4 | JCR Q3 |
| 101 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2.3 | JCR Q3 |
| 102 | PHARMACOPSYCHIATRY | 2.3 | JCR Q3 |
| 103 | Drugs in Context | 2.2 | JCR Q3 |
| 104 | JOURNAL OF CLINICAL PHARMACOLOGY | 2.2 | JCR Q3 |
| 105 | Pharmacy | 2.2 | JCR Q3 |
| 106 | Clinical Pharmacology-Advances and Applications | 2.1 | JCR Q3 |
| 107 | HIV Research & Clinical Practice | 2.1 | JCR Q3 |
| 108 | ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES | 2.1 | JCR Q3 |
| 109 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 1.8 | JCR Q2 |
| 110 | EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY | 1.6 | JCR Q3 |
| 111 | JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 1.4 | JCR Q3 |